News & Updates

Vortioxetine may help cannabis users improve their clinician-observed overall mood state, a pilot study has shown.

An analytic cohort study in Hong Kong has shown that clozapine is associated with a rare but two-fold increased rate of haematological malignancy. Special warnings or more restrictive indications for its use may not be necessary.

Treatment with the allosteric cardiac myosin inhibitor mavacamten in severely symptomatic patients with obstructive HCM allows for the deferral of invasive SRT for nearly 2.5 years, as shown in the end-of-trial results of VALOR-HCM presented at AHA 2024

New drug applications approved by US FDA as of 16-31 December 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Daily coffee drinking may provide atrial fibrillation (AF) patients with cognitive benefits, as suggested in a study.

The reasons why continuous positive airway pressure (CPAP) treatment has not been shown to reduce cardiovascular (CV) events in randomized trials on obstructive sleep apnoea (OSA) are multifaceted. However, research still suggests that such patients can benefit from CPAP, according to an evidence review presented at APSR 2024.